Pharmacogenetic Risk for Adverse Reactions to Irinotecan in the Major Ethnic Populations of Singapore: Regulatory Evaluation by the Health Sciences Authority

Author： Sung Cynthia   >   Tan Liesbet L.   Toh Dorothy S.L.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.12, 2011-12, pp. : 1167-1175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacogenetic basis of adverse drug reactions

By John C.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 83-84

Adis International

Access to resources Recommend Favorite

Following an alert from the Singapore Health Sciences Authority, Health Canada has advised consumers not to use Urat Madu

By  

Reactions Weekly, Vol. 1, Iss. 1151, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The Pharmacovigilance Unit of Singapore's Health Sciences Authority received 1139 spontaneous ADR reports in 2004

By  

Reactions Weekly, Vol. 1, Iss. 1051, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The Pharmacovigilance Unit of Singapore's Health Sciences Authority received 1139 spontaneous ADR reports in 2004

By  

Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Singapore's Health Sciences Authority has received four reports of unusual sleep-related disorders in patients receiving zolpidem.

By  

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite